GR3030718T3 - Novel prostaglandin analogue. - Google Patents

Novel prostaglandin analogue.

Info

Publication number
GR3030718T3
GR3030718T3 GR990401801T GR990401801T GR3030718T3 GR 3030718 T3 GR3030718 T3 GR 3030718T3 GR 990401801 T GR990401801 T GR 990401801T GR 990401801 T GR990401801 T GR 990401801T GR 3030718 T3 GR3030718 T3 GR 3030718T3
Authority
GR
Greece
Prior art keywords
prostaglandin analogue
novel prostaglandin
novel
analogue
chem
Prior art date
Application number
GR990401801T
Other languages
English (en)
Inventor
Yutaka Mizushima
Toshihide Inomata
Arata Yasuda
Original Assignee
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp filed Critical Green Cross Corp
Publication of GR3030718T3 publication Critical patent/GR3030718T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
GR990401801T 1989-10-16 1999-07-07 Novel prostaglandin analogue. GR3030718T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1266230A JP2602964B2 (ja) 1989-10-16 1989-10-16 プロスタグランジン類縁体およびその脂肪乳剤
EP90119772A EP0423697B1 (en) 1989-10-16 1990-10-15 Emulsion of lipid containing a prostaglandin analogue

Publications (1)

Publication Number Publication Date
GR3030718T3 true GR3030718T3 (en) 1999-11-30

Family

ID=17428079

Family Applications (2)

Application Number Title Priority Date Filing Date
GR950401086T GR3015963T3 (en) 1989-10-16 1995-04-28 Emulsion of lipid containing a prostaglandin analogue.
GR990401801T GR3030718T3 (en) 1989-10-16 1999-07-07 Novel prostaglandin analogue.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR950401086T GR3015963T3 (en) 1989-10-16 1995-04-28 Emulsion of lipid containing a prostaglandin analogue.

Country Status (10)

Country Link
US (1) US5120870A (el)
EP (2) EP0423697B1 (el)
JP (1) JP2602964B2 (el)
AT (2) ATE179169T1 (el)
AU (1) AU641436B2 (el)
CA (1) CA2027351C (el)
DE (2) DE69033069T2 (el)
DK (2) DK0423697T3 (el)
ES (2) ES2070238T3 (el)
GR (2) GR3015963T3 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69533150T2 (de) * 1994-01-18 2005-07-07 Teijin Ltd. 7-thiaprostaglandine und verfahren zu ihrer herstellung
WO1999009992A1 (fr) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
DE69939826D1 (de) * 1998-06-04 2008-12-11 Ltt Bio Pharma Co Ltd Verfahren zur herstellung eines gereinigten prostaglandin-derivats
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
JP2005504090A (ja) 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
JP2003342196A (ja) * 2002-05-31 2003-12-03 Mukku:Kk 静脈注射用組成物、その製造法およびその製剤
EP1711163A2 (en) * 2004-02-05 2006-10-18 Baxter International Inc. Dispersions prepared by use of self-stabilizing agents
ATE412400T1 (de) 2004-11-09 2008-11-15 Novagali Pharma Sa Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential
CA2578176C (en) * 2004-11-09 2013-09-24 Novagali Pharma Sa Ophthalmic emulsions containing an immunosuppressive agent
CA2625568C (en) * 2005-10-10 2013-10-08 Novagali Pharma Sa Ophthalmic emulsions containing prostaglandins
US8334321B2 (en) 2006-09-05 2012-12-18 Q.P. Corporation Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US10272040B2 (en) 2010-08-12 2019-04-30 Nanyang Technological University Liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363817A (en) * 1981-08-27 1982-12-14 Miles Laboratories, Inc. Enol acylate analogs of E1 and E2 prostaglandins
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
JPS59216820A (ja) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
JPS61151126A (ja) * 1984-12-25 1986-07-09 Teijin Ltd △７―プロスタグランジンａ１類を有効成分として含有する注射用の脂肪乳剤

Also Published As

Publication number Publication date
US5120870A (en) 1992-06-09
DK0624574T3 (da) 1999-10-25
DK0423697T3 (da) 1995-05-29
ES2132279T3 (es) 1999-08-16
CA2027351A1 (en) 1991-04-17
ES2070238T3 (es) 1995-06-01
EP0423697A2 (en) 1991-04-24
DE69016567D1 (de) 1995-03-16
CA2027351C (en) 2001-06-19
DE69033069D1 (de) 1999-05-27
ATE117989T1 (de) 1995-02-15
JP2602964B2 (ja) 1997-04-23
EP0624574A2 (en) 1994-11-17
AU641436B2 (en) 1993-09-23
AU6452690A (en) 1991-04-18
EP0624574A3 (en) 1995-01-18
JPH03204853A (ja) 1991-09-06
EP0423697A3 (en) 1992-08-05
ATE179169T1 (de) 1999-05-15
EP0624574B1 (en) 1999-04-21
GR3015963T3 (en) 1995-07-31
DE69016567T2 (de) 1995-09-21
DE69033069T2 (de) 1999-08-19
EP0423697B1 (en) 1995-02-01

Similar Documents

Publication Publication Date Title
GR3030718T3 (en) Novel prostaglandin analogue.
GR3024255T3 (en) Benzo-fused lactams
IL111843A0 (en) Preparation of 3,4,4-trisubstituted-piperidinyl-n-alkylcarboxylates and intermediates
DE3175042D1 (en) 7-oxo-4-thia-1-aza(3,2,0)heptane and 7-oxo-4-thia-1-aza(3,2,0)hept-2-ene derivatives
PL286043A1 (en) Method for manufacturing new proteins
UA6330A1 (uk) Спосіб одержання похідних бензаміда
GR3007079T3 (el)
HK1000109A1 (en) Process for the preparation of 3,3-diaryl acrylic acid amides 3,3-
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
AU568694B2 (en) N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine
PL291199A1 (en) Method of synthesizing 6-/aminopropionyl substituted/ forskolin derivatives
GR3006806T3 (el)
EP0422523A3 (en) Process for the preparation of cyclic carbonates
IL88177A0 (en) Preparation of halo substituted isothiazolones
ZA899821B (en) Novel compounds
IN170286B (el)
PH24971A (en) N2-thiocylcarbazate compounds and derivatives thereof
GB8600879D0 (en) Pregnane derivatives
GR3019381T3 (en) 3-Anilino-2-hydroxycarbonyl-4-thiophen-acetic acids
GR3022259T3 (en) Tetrahydro-4-phenylimino-3-thiophen-acetic acids